Testicular Myeloid Sarcoma — Rankings

Testicular Myeloid Sarcoma — Rankings · CancerIndex

Rankings

Why this rank?

2 current ranking rows (latest year per scope). Each row lists the scope, the formula version, the value and the exact inputs that produced it.

Metric	Scope	Rank / eligible	Δ	Value	Percentile	Confidence	Formula	Generated	Inputs
Publications, last 12 months	World · both sexes · all ages · latest · all malignant entities	#1866 / 2,294	=	1 count	18.7	Medium confidence	ci-pubs-12m-v1	Sep 30, 2026	show formula: literature_counts.count WHERE window_key = 12m counter publicationCount12m computedAt 2026-09-30T02:02:21.255Z inputs hash 6636ad9f834652e029647409 Trace lineage (admin)
Publications, last 5 years	World · both sexes · all ages · latest · all malignant entities	#1900 / 2,873	=	7 count	33.9	Medium confidence	ci-pubs-5y-v1	Sep 30, 2026	show formula: literature_counts.count WHERE window_key = 5y (query stored per row) counter publicationCount5y computedAt 2026-09-30T02:02:21.255Z inputs hash 531d42217f151c0dd79899a6 Trace lineage (admin)

Computed Ranks are competition ranks (ties share a rank). Percentile = share of eligible entities ranked at or below this one in the ranking direction.

"Deadliest" is ambiguous: annual deaths, age-standardized mortality rate, mortality-to-incidence ratio and 5-year survival rank cancers differently. CancerIndex publishes each as a separate metric.

Why this rank?

Research gap